Apply for a subscription
or request a trial

If you'd like to subscribe to Mergermarket or inquire about a trial, please contact us.

  • This field is for validation purposes and should be left unchanged.

Prefer to call or email?

Americas

+1 212 500 7537 / Email Sales Americas

EMEA

+44 (0)20 7010 6326 / Email Sales EMEA

Asia

+852 2158 9764 / Email Sales Asia

Australasia

+61 2 9467 6646 / Email Sales Australasia

Global Q1-Q3 2013 Pharma, Medical, and Biotech M&A Trend Report

Mergermarket releases its Global Q1-Q3 2013 Pharma, Medical, and Biotech M&A Trend Report

Highlights include:

• Global M&A activity in the Pharma, Medical & Biotech (PMB) has increased 26.1% compared to the same period in 2012 (up until end of October) with US$ 141bn-worth of deals compared to US$ 111.8bn this time last year.

• After a drop in M&A value in Q1 to US$ 13.9bn from Q4 2012’s three and a half year high (US$ 80.8bn), the quarterly value has been sporadic throughout 2013. Q3’s US$ 49.1bn-worth of deals was down 24% from Q2 (US$ 64.6bn) but compared to Q3 2012’s US$ 27bn, it showed a sharp 81.9% increase.

• The PMB sector has fluctuated in value every year since 2007 (US$ 219.8bn). Last year’s US$ 180.5bn-worth of deals marked the third time to see an annual decrease since 2007, down 10.4% from 2011 (US$ 201.5bn) even though the number of deals has increased every year since 2009 which has led to 2012 ending with 1,030 deals.

Please see here for the full report.

Sign in to mergermarket

Forgotten your password?

This message can be edited in Snippets > Forgotten Password message.